A Study of Drug Repurposing to Identify SARS-CoV-2 Main Protease (3CLpro) Inhibitors

The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) wreaked havoc all over the world. Although vaccines for the disease have recently become available and started to be administered to the population in various countries, there i...

Descripción completa

Detalles Bibliográficos
Autores principales: Jo, Seri, Signorile, Luca, Kim, Suwon, Kim, Mi-Sun, Huertas, Oscar, Insa, Raúl, Reig, Núria, Shin, Dong Hae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224295/
https://www.ncbi.nlm.nih.gov/pubmed/35742913
http://dx.doi.org/10.3390/ijms23126468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224295/
https://www.ncbi.nlm.nih.gov/pubmed/35742913
http://dx.doi.org/10.3390/ijms23126468

Ejemplares similares